Table of Contents
Thrombosis
Volume 2011 (2011), Article ID 874146, 8 pages
http://dx.doi.org/10.1155/2011/874146
Research Article

Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms

1Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
2Biostatistics Core, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
3Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Received 27 February 2011; Accepted 26 May 2011

Academic Editor: Francesco Dentali

Copyright © 2011 Brady L. Stein et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. R. Moliterno, D. M. Williams, O. Rogers, and J. L. Spivak, “Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mp1 expression,” Blood, vol. 108, no. 12, pp. 3913–3915, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Videbaek, “Polycythaemia vera: course and prognosis,” Acta Medica Scandinavica, vol. 138, no. 3, pp. 179–187, 1950. View at Google Scholar · View at Scopus
  3. B. L. Stein, D. M. Williams, N. Wang et al., “Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders,” Haematologica, vol. 95, no. 7, pp. 1090–1096, 2010. View at Publisher · View at Google Scholar
  4. M. N. Silverstein and W. H. ReMine, “Sex, splenectomy, and myeloid metaplasia,” Journal of the American Medical Association, vol. 227, no. 4, pp. 424–426, 1974. View at Publisher · View at Google Scholar · View at Scopus
  5. D. E. Rollison, N. Howlader, M. T. Smith et al., “Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs,” Blood, vol. 112, no. 1, pp. 45–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Passamonti, E. Rumi, E. Pungolino et al., “Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia,” American Journal of Medicine, vol. 117, no. 10, pp. 755–761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Barbui, A. Carobbio, F. Cervantes et al., “Thrombosis in primary myelofibrosis: incidence and risk factors,” Blood, vol. 115, no. 4, pp. 778–782, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Lloyd-Jones, R. J. Adams, T. M. Brown et al., “Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association,” Circulation, vol. 121, no. 7, pp. 948–954, 2010. View at Google Scholar
  9. A. Towfighi, J. L. Saver, R. Engelhardt, and B. Ovbiagele, “A midlife stroke surge among women in the United States,” Neurology, vol. 69, no. 20, pp. 1898–1904, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Montagnana, E. J. Favaloro, M. Franchini, G. C. Guidi, and G. Lippi, “The role of ethnicity, age and gender in venous thromboembolism,” Journal of Thrombosis and Thrombolysis, vol. 29, no. 4, pp. 489–496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. McRae, H. Tran, S. Schulman, J. Ginsberg, and C. Kearon, “Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis,” Lancet, vol. 368, no. 9533, pp. 371–378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. R. H. White, W. E. Dager, H. Zhou, and S. Murin, “Racial and gender differences in the incidence of recurrent venous thromboembolism,” Thrombosis and Haemostasis, vol. 96, no. 3, pp. 267–273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. D. Berk, J. D. Goldberg, P. B. Donovan, S. M. Fruchtman, N. I. Berlin, and L. R. Wasserman, “Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols,” Seminars in Hematology, vol. 23, no. 2, pp. 132–143, 1986. View at Google Scholar · View at Scopus
  14. S. Murphy, P. Peterson, H. Iland, and J. Laszlo, “Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment,” Seminars in Hematology, vol. 34, no. 1, pp. 29–39, 1997. View at Google Scholar · View at Scopus
  15. G. Barosi, “Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines,” Journal of Clinical Oncology, vol. 17, no. 9, pp. 2954–2970, 1999. View at Google Scholar · View at Scopus
  16. R. A. Mesa, S. Verstovsek, F. Cervantes et al., “Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT),” Leukemia Research, vol. 31, no. 6, pp. 737–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Alvarez-Larrán, F. Cervantes, A. Pereira et al., “Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia,” Blood, vol. 116, no. 8, pp. 1205–1210, 2010. View at Publisher · View at Google Scholar
  18. A. Carobbio, G. Finazzi, E. Antonioli et al., “Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria,” Blood, vol. 116, no. 7, pp. 1051–1055, 2010. View at Publisher · View at Google Scholar
  19. R. Marchioli, G. Finazzi, R. Landolfi et al., “Vascular and neoplastic risk in a large cohort of patients with polycythemia vera,” Journal of Clinical Oncology, vol. 23, no. 10, pp. 2224–2232, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Primignani, G. Barosi, G. Bergamaschi et al., “Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis,” Hepatology, vol. 44, no. 6, pp. 1528–1534, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Colaizzo, L. Amitrano, G. L. Tiscia et al., “The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis,” Journal of Thrombosis and Haemostasis, vol. 5, no. 1, pp. 55–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. J. Kiladjian, F. Cervantes, F. W. G. Leebeek et al., “The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases,” Blood, vol. 111, no. 10, pp. 4922–4929, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Colaizzo, G. L. Tiscia, V. Bafunno et al., “Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis,” Thrombosis Research. In press. View at Publisher · View at Google Scholar
  24. R. Landolfi, R. Marchioli, J. Kutti et al., “Efficacy and safety of low-dose aspirin in polycythemia vera,” New England Journal of Medicine, vol. 350, no. 2, pp. 114–124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Carobbio, G. Finazzi, V. Guerini et al., “Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status,” Blood, vol. 109, no. 6, pp. 2310–2313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Vannucchi, E. Antonioli, P. Guglielmelli et al., “Prospective identification of high-risk polycythemia vera patients based on JAK2 allele burden,” Leukemia, vol. 21, no. 9, pp. 1952–1959, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. B. L. Stein and A. R. Moliterno, “Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation,” Journal of the American Medical Association, vol. 303, no. 24, pp. 2513–2518, 2010. View at Publisher · View at Google Scholar · View at Scopus